171 related articles for article (PubMed ID: 34888235)
1. Case Report: Malignant Primary Sellar Paraganglioma With Unusual Genetic and Imaging Features.
Stojanoski S; Boldt HB; Kozic D; Patócs A; Korbonits M; Medic-Stojanoska M; Casar-Borota O
Front Oncol; 2021; 11():739255. PubMed ID: 34888235
[TBL] [Abstract][Full Text] [Related]
2. Case Report: Paraganglioma in the sellar region: longitudinal observation and surgical outcome.
Wang Y; Yang X; Ma Q; Nicholas VH; Sun J; Zhao X; Liu W; Yang C
Front Oncol; 2023; 13():1090615. PubMed ID: 37287917
[TBL] [Abstract][Full Text] [Related]
3. Molecular evaluation of a sporadic paraganglioma with concurrent IDH1 and ATRX mutations.
Zhang J; Jiang J; Luo Y; Li X; Lu Z; Liu Y; Huang J; Hou Y; Pang Y; Sun MYF; Wang TS; Evans DB; Pacak K; Zhuang Z; Gao X
Endocrine; 2018 Aug; 61(2):216-223. PubMed ID: 29846902
[TBL] [Abstract][Full Text] [Related]
4. Intrasellar paraganglioma: a case report and review of the literature.
Boari N; Losa M; Mortini P; Snider S; Terreni MR; Giovanelli M
Acta Neurochir (Wien); 2006 Dec; 148(12):1311-4; discussion 1314. PubMed ID: 17039304
[TBL] [Abstract][Full Text] [Related]
5. Paraganglioma in pituitary fossa.
Ozüm U; Eğilmez R; Yildirim A
Neuropathology; 2008 Oct; 28(5):547-50. PubMed ID: 18410271
[TBL] [Abstract][Full Text] [Related]
6. Serotonin, ATRX, and DAXX Expression in Pituitary Adenomas: Markers in the Differential Diagnosis of Neuroendocrine Tumors of the Sellar Region.
Casar-Borota O; Botling J; Granberg D; Stigare J; Wikström J; Boldt HB; Kristensen BW; Pontén F; Trouillas J
Am J Surg Pathol; 2017 Sep; 41(9):1238-1246. PubMed ID: 28719461
[TBL] [Abstract][Full Text] [Related]
7. Gamma Knife Radiosurgery: An Adjuvant Therapy for Primary Sellar Paraganglioma.
Bajagain M; Fujio S; Kirishima M; Yatsushiro K; Hanaya R
Cureus; 2024 Mar; 16(3):e56228. PubMed ID: 38618302
[TBL] [Abstract][Full Text] [Related]
8. Gamma Knife radiosurgery for sellar and parasellar meningiomas: a multicenter study.
Sheehan JP; Starke RM; Kano H; Kaufmann AM; Mathieu D; Zeiler FA; West M; Chao ST; Varma G; Chiang VL; Yu JB; McBride HL; Nakaji P; Youssef E; Honea N; Rush S; Kondziolka D; Lee JY; Bailey RL; Kunwar S; Petti P; Lunsford LD
J Neurosurg; 2014 Jun; 120(6):1268-77. PubMed ID: 24678777
[TBL] [Abstract][Full Text] [Related]
9. Paraganglioma of the pituitary fossa: diagnosis and management.
Salame K; Ouaknine GE; Yossipov J; Rochkind S
J Neurooncol; 2001 Aug; 54(1):49-52. PubMed ID: 11763422
[TBL] [Abstract][Full Text] [Related]
10. Juvenile Xanthogranuloma of the Sellar Region with a 5-Year Medical History: Case Report and Literature Review.
Cheng D; Yang F; Li Z; Qv F; Liu W
Pediatr Neurosurg; 2021; 56(5):440-447. PubMed ID: 34192694
[TBL] [Abstract][Full Text] [Related]
11. Peptide receptor radionuclide therapy in patients with metastatic progressive pheochromocytoma and paraganglioma: long-term toxicity, efficacy and prognostic biomarker data of phase II clinical trials.
Severi S; Bongiovanni A; Ferrara M; Nicolini S; Di Mauro F; Sansovini M; Lolli I; Tardelli E; Cittanti C; Di Iorio V; Mezzenga E; Scarpi E; Ibrahim T; Paganelli G; Zovato S
ESMO Open; 2021 Aug; 6(4):100171. PubMed ID: 34139487
[TBL] [Abstract][Full Text] [Related]
12. 68Ga-DOTANOC PET/CT for baseline evaluation of patients with head and neck paraganglioma.
Sharma P; Thakar A; Suman K C S; Dhull VS; Singh H; Naswa N; Reddy RM; Karunanithi S; Kumar R; Kumar R; Malhotra A; Bal C
J Nucl Med; 2013 Jun; 54(6):841-7. PubMed ID: 23520216
[TBL] [Abstract][Full Text] [Related]
13. Primary Sellar Paraganglioma: Case Report with Literature Review and Immunohistochemistry Resource.
Lyne SB; Polster SP; Fidai S; Pytel P; Yamini B
World Neurosurg; 2019 May; 125():32-36. PubMed ID: 30703592
[TBL] [Abstract][Full Text] [Related]
14. Sellar Paraganglioma.
Karlekar M; Kumar S; Jadhav S; Lila A; Bandgar T; Shah N
Clin Nucl Med; 2018 Aug; 43(8):591-592. PubMed ID: 29894338
[TBL] [Abstract][Full Text] [Related]
15. Role of [68Ga]DOTANOC PET/computed tomography and [131I]MIBG scintigraphy in the management of patients with pheochromocytoma and paraganglioma: a prospective study.
Singh D; Shukla J; Walia R; Vatsa R; Paul N; Chhabra A; Nahar U; Singh H; Kumar R; Bhansali A; Rai Mittal B
Nucl Med Commun; 2020 Oct; 41(10):1047-1059. PubMed ID: 32732602
[TBL] [Abstract][Full Text] [Related]
16. Role of
Jha A; Patel M; Baker E; Gonzales MK; Ling A; Millo C; Knue M; Civelek AC; Pacak K
Nucl Med Mol Imaging; 2020 Feb; 54(1):48-52. PubMed ID: 32206131
[TBL] [Abstract][Full Text] [Related]
17. Sellar-Suprasellar Paraganglioma: Report of 2 Cases and Review of Literature.
Vasoya P; Aryan S; Thakar S; Sivaraju L; Ghosal N; Hegde AS
World Neurosurg; 2020 Aug; 140():293-300. PubMed ID: 32413561
[TBL] [Abstract][Full Text] [Related]
18. Pituitary magnetic resonance imaging for sellar and parasellar masses: ten-year experience in 2598 patients.
Famini P; Maya MM; Melmed S
J Clin Endocrinol Metab; 2011 Jun; 96(6):1633-41. PubMed ID: 21470998
[TBL] [Abstract][Full Text] [Related]
19. PET-guided repeat transsphenoidal surgery for previously deemed unresectable lateral disease in acromegaly.
Bashari WA; Senanayake R; Koulouri O; Gillett D; MacFarlane J; Powlson AS; Fernandez-Pombo A; Bano G; Martin AJ; Scoffings D; Cheow H; Mendichovszky I; Tysome J; Donnelly N; Santarius T; Kolias A; Mannion R; Gurnell M
Neurosurg Focus; 2020 Jun; 48(6):E8. PubMed ID: 32480379
[TBL] [Abstract][Full Text] [Related]
20. Case Report: Primary Hypothyroidism Associated With Lutetium 177-DOTATATE Therapy for Metastatic Paraganglioma.
Gubbi S; Al-Jundi M; Del Rivero J; Jha A; Knue M; Zou J; Turkbey B; Carrasquillo JA; Lin E; Pacak K; Klubo-Gwiezdzinska J; Lin FI
Front Endocrinol (Lausanne); 2020; 11():587065. PubMed ID: 33551992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
